24 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 30, 03:35 PM
Fredun Pharmaceuticals Ltd.

BSE

  • 61.00 0.00 (0%)
  • Vol: 5
  • BSE Code: 539730
  • PREV. CLOSE
    61.00
  • OPEN PRICE
    61.00
  • BID PRICE (QTY.)
    61.00(59944)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

Fredun Pharmaceuticals Ltd. Board Meetings

From date
To date
Source Date Board Meeting Date Details
19-Apr-201705-May-2017 Redemption of the Preference shares and issue of Equity shares under the preferential guidelines
20-Mar-201724-Mar-2017Fredun Pharmaceuticals Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on the March 24, 2017 to discuss, consider and approve the matter of, obtaining Loan/Credit facility of upto 1 Crore 50 Lakhs from Indusind Bank for a period of 90 days/3 months.
17-Feb-201724-Feb-2017Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 24, 2017, to discuss, consider and approve the matter of the Increasing Authorised Capital of the Company.
30-Jan-201713-Feb-2017 Quarterly Results
12-Jan-201718-Jan-2017 Fredun Pharmaceuticals Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on January 18, 2017, for the purpose of- 1. To consider obtaining on lease a property for storage purposes for a period of 12 months. 2. To consider the matter of obtaining a Loan from Fredun Healthcare Private Limited. 3. To consider the matter of obtaining a Loan from one or more NBFC(s) if required.
07-Nov-201609-Nov-2016 Quarterly Results & Fredun Pharmaceuticals Ltd has informed BSE that a Meeting of the Board of Directors of the Company will be held on November 09, 2016, for the purpose of; 1. To consider approve and take on records the un-audited quarterly and six-monthly financial results as on September 30, 2016; and 2. To consider availing credit facility of Rs. 1,00,00,000 (One Crore) from Induslnd Bank (Bankers to the Company).
30-Sep-201607-Oct-2016 Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 07, 2016, to consider obtaining on lease premises for office use.
04-Aug-201611-Aug-2016 Quarterly Results
07-Jun-201608-Jun-2016 Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on June 08, 2016 to consider, approve and allot 8% Redeemable Non Convertible Cumulative Preference shares to the extent of Rs. 2.50 Crores as per the Resolution passed under Section 42,55,62 and other applicable rules under The Companies Act, 2013 by the shareholders of the Company at an Extra Ordinary General Meeting of the Company held on May 30, 2016.
13-May-201630-May-2016 Audited Results
21-Apr-201627-Apr-2016Fredun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on April 27, 2016, to consider and approve the matter of issuing Redeemable Preference shares and to hold an Extra Ordinary General Meeting in this respect. The Redeemable Preference shares may not be listed subject to all the Regulations and The Companies Act, 2013.
28-Mar-201631-Mar-2016 Interim Dividend & A meeting of the Board of Directors of the Company will be held on March 31, 2016, to consider the following matter: 1. To declare the Interim Dividend. 2. To discuss, consider and approve the issue of Equity shares of the Company to the investors under the preferential Guidelines.